ENTRADA THERAPEUTICS, INC. (TRDA) Operating cash flow 2020–2025
ENTRADA THERAPEUTICS, INC. (TRDA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$128.5MFY2025 · since FY2020: -$25.6M → -$128.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$128.5M | -209.2% |
| FY2024 | -$41.6M | -129.7% |
| FY2023 | $139.8M | +249.1% |
| FY2022 | -$93.8M | -84.4% |
| FY2021 | -$50.9M | -98.9% |
| FY2020 | -$25.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice